7 results
Reduced DOAC Dosing for Atrial Fibrillation 

#DOAC #Reduced #Dosing #Reduction #Dose #Anticoagulation #Pharmacology #AFib #Renal #CKD
Reduction #Dose #Anticoagulation ... #Pharmacology # ... AFib #Renal #CKD ... AtrialFibrillation #Indications
Oral Antihypertensive Medications - Selection by Comorbidities
Comorbidities: 
 • Stable Angina, HFpEF, HFrEF, AFib, TAA/Marfan, Aortic
Medications - Selection ... HFpEF, HFrEF, AFib ... Dissection • CKD ... Antihypertensive #Medications ... Comorbidities #pharmacology
Beta Blockers - Pharmacology Comparison Table
Metoprolol:
 • Receptors: β1
 • Indications: Rate control of a-fib/a-flutter, Suppression
Beta Blockers - Pharmacology ... Receptors: β1 • Indications ... Rate control of a-fib ... Rate control of a-fib ... indicated in pt w/o CAD
Antiplatelet Medications - Summary Table

Aspirin - Inhibits cyclooxygenase, preventing formation of thromboxane A2
 • Acute coronary
Antiplatelet Medications ... inhibitor and anticoagulation ... in a-fib P2Y12 ... #Antiplatelet #Medications ... Summary #Table #Pharmacology
Atrial Fibrillation (A-Fib) Summary

Symptoms:
• Palpitations, light-headedness, dizziness, dyspnea, exercise intolerance, chest pain, near-syncope, syncope.

Why?
Cardiac:
	• Valvular heart
Fibrillation (A-Fib ... control with early Afib ... Absolute warfarin indications ... Mechanical heart valve ... #Fibrillation #AFib
Intern Pocket Cards - Pharmacologic Pain Management Options
Anti-inflammatory:
 • Acetaminophen (24 hours: < 3-4g in healthy
Pocket Cards - Pharmacologic ... adults, <3g in CKD ... cirrhosis) • Oral ... steroids, on ASA/anticoagulation ... Table #Ladder #medications
SLE (Systemic Lupus Erythematosus)

Suspect:
Clinical evidence of (fatigue, rash, photosensitivity, inflammatory arthritis, weight loss, and fever) and
folds • Painless oral ... Valvular disorders • CAD ... Cytopenias • Cardiac valve ... vegetations APLA ... activation and/or medications